v3.26.1
Organization and Nature of Business - Schedule of Investments in Subsidiaries (Details)
6 Months Ended
Jun. 30, 2026
USD ($)
VAXIMM AG (“VAXIMM”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital $ 707,884
Percentage of ownership 100.00%
Principal activities Biotech (drug development)
Country of incorporation Switzerland
RMC Co., Ltd. (“RMC”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital $ 22,705
Percentage of ownership 100.00%
Principal activities Medical device distribution
Country of incorporation Republic of Korea
Darnatein Co., Ltd. (“Darnatein”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital $ 4,195,048
Percentage of ownership 100.00%
Principal activities Biotech (drug development)
Country of incorporation Republic of Korea
OSR Holdings, Inc. ("OSRI") [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital $ 3,299
Percentage of ownership 100.00%
Principal activities NASDAQ Listed Company
Country of incorporation The United States
Woori-IO Co., Ltd. (“Woori-IO”) [Member]  
Schedule of Investments in Subsidiaries [Line Items]  
Share capital $ 288,326
Percentage of ownership 100.00%
Principal activities Medical device development
Country of incorporation Republic of Korea